Thai traditional medicine regulation: what a 'traditional drug' is and which law applies today

Thai traditional medicine regulation: where the term 'traditional drug' comes from
Thai traditional medicine regulation changed in 2019, but many labels, contracts and supplier documents still use the old Thai term ya phaen boran, usually translated as "traditional drug". Foreign brand owners and importers meet it on balms, powders, herbal pills and many other herbal medicines. The term comes from a real statute, the Drug Act B.E. 2510 (1967), which governed herbal medicines before Thailand had a dedicated herbal products law.
Section 4 of the Drug Act defines a traditional drug as a drug intended for use in the practice of traditional medicine or in veterinary practice that meets any one of these conditions:
- It appears in a traditional drug pharmacopoeia announced by the Minister.
- The Minister has announced it as a traditional drug.
- It has been registered as a traditional drug formula.
The definition separates traditional drugs from modern drugs, which are intended for medical practice or modern healing arts. Section 49 of the Drug Act also created three licences specific to traditional drugs: a licence to manufacture, a licence to sell, and a licence to import traditional drugs.
This article explains what a traditional drug means under current Thai law, and what happens to a product registered as one.
The Herbal Products Act B.E. 2562 (2019) moved traditional drugs under herbal law
The Herbal Products Act B.E. 2562 (2019) was published in the Royal Gazette on 30 April 2019 and took effect sixty days later.
Section 4 of the new Act defines "herbal products" in four groups. The first group is drugs from herbs, which the Act says include Thai traditional medicines, herbal-derived drugs, traditional drugs for human use under the drug law, and drugs based on alternative medicine knowledge intended for human illness or disease prevention. The other three groups are herbal health products, ingredients, and anything else the Minister designates.
Two points matter for businesses:
- Only traditional drugs for human use moved to the herbal products law. The Act expressly excludes traditional drugs for animals from the definition of herbal products.
- No double compliance. Section 3 exempts herbal products handled under this Act from also complying with the drug law or the food law.
The definition excludes modern drugs, foods, cosmetics and medical devices, so a product containing herbs is not automatically a herbal product. If unsure, try the product classification tool.

Transitional provisions: old registrations, old licences and pending applications
Changing the law did not cancel documents already issued. The Herbal Products Act has four transitional sections that matter directly to businesses:
- Section 124, existing licences. Licences to manufacture, import or sell drugs or foods that are herbal products, issued under the drug or food law before the new Act, remain valid until they expire, including traditional drug licences.
- Section 125, existing registrations. Drug and food registrations for herbal products remain valid until they expire, and stock made or imported before then may be sold until the product expires or the authority orders otherwise.
- Section 126, pending applications. Herbal product applications filed under the drug or food law and still under review are deemed applications under the new Act, and the authority may order them amended.
- Section 127, existing regulations. Old regulations and notifications for herbal products continue to apply where they do not conflict with the new Act, until replaced.
Clause 15 of the 2020 licensing Ministerial Regulation confirms that unexpired old licences stay valid until they expire, and clause 16 of the 2020 registration Ministerial Regulation sets different expiry points for old drug registrations depending on when they were granted, so each old traditional drug registration must be checked individually.
- 1Existing licencesValid until expiry, Section 124
- 2Existing registrationsValid until expiry, Section 125
- 3Stock already madeMay be sold until the product expires or an order is made
- 4Pending applicationsDeemed applications under the new Act, Section 126
- 5Old regulationsApply where not in conflict until replaced, Section 127
Source: Herbal Products Act B.E. 2562 (2019), Sections 124–127
How a former traditional drug is classified today
The new Act no longer uses "traditional drug" as a main category. A product once registered as a traditional drug is now read against the definitions in Section 4 of the Herbal Products Act:
- Thai traditional medicine: a drug obtained directly from herbs, or by mixing, compounding or transforming herbs, intended for use according to Thai traditional medical knowledge, or a drug the Minister declares to be one. Most classic formulas called traditional drugs belong here.
- Drugs based on alternative medicine knowledge: the example backed by a notification is Chinese traditional medicine, which a 2022 Ministry of Public Health notification defines as herbal medicine intended for use according to Chinese medicine.
- Herbal-derived drugs: drugs obtained from herbs that are neither Thai traditional medicines nor alternative medicine drugs, such as the turmeric drug for which the general-sale list sets a minimum curcuminoid content.
- Herbal health products: the second group in Section 4, meant to improve health or body function rather than to act as a drug.
The category decides who must serve as the responsible person, what the label may say, and which sales channel applies.
"Herbal medicine" in everyday English can mean any of these four groups, so pin down the category before designing a label.
Source: Herbal Products Act B.E. 2562, Section 4, and the 2022 notification on responsible persons
Product evidence today: registration, detailed notification or notification
The Herbal Products Act does not list which product needs which approval. Section 6 lets the Minister decide by notification, and the Act sets three levels of product evidence:
- Registration under Section 34, which the 2021 Ministry of Public Health notification applies to herbal drugs and herbal health products that do not qualify for notification or detailed notification.
- Detailed notification under Section 45, which the 2021 notification applies to products that differ from a listed formula in specified ways that do not affect quality, efficacy or safety.
- Notification under Section 45, for products that match a listed formula.
For Thai traditional medicines, the fourth Ministry of Public Health notification on herbal products requiring registration, detailed notification or notification, B.E. 2569 (2026), cancels the lists of the 2021 notification as amended by the third edition of 2023 and replaces them. List 1 holds 208 Thai traditional formulas, list 2 holds 15 herbal-derived drugs and list 3 holds 88 herbal health products. Notification and detailed-notification receipts issued before it took effect remain valid until they expire.
The old "traditional drug registration" is therefore replaced by a herbal product registration certificate, detailed-notification receipt or notification receipt, depending on how closely the formula matches the lists. All three are valid for five years under Sections 39 and 49.
Reference texts for applications are set by the 2022 notification on texts related to herbal products and its 2025 second edition, playing a role similar to the traditional drug pharmacopoeia in the old law.
For which products qualify for notification and what to prepare, read herbal product notification in Thailand.
Traditional drug factories, importers and the responsible person
Section 17 of the Herbal Products Act requires anyone manufacturing, importing or selling herbal products designated under Section 6 (1) to obtain a licence first. Section 20 creates three licences: to manufacture, to import and to sell herbal products.
The 2020 notification on herbal products requiring a licence requires manufacturers and importers of all herbal product groups to be licensed, except simple processing of herbs by community enterprises or small farmers under set conditions.
A former traditional drug factory is now a herbal product manufacturing site and must follow the herbal product manufacturing criteria, covered in herbal product GMP in Thailand. Importers can read about ports of entry and documents in importing herbal products into Thailand.
The responsible person. The 2022 notification on the qualifications, number and duties of responsible persons requires at least one at each manufacturing or import site, qualified for the product type:
- Thai traditional medicines: a Thai traditional medicine practitioner in Thai pharmacy or Thai medicine, or an applied Thai traditional medicine practitioner.
- Chinese traditional medicines: a licensed Chinese medicine practitioner.
- Herbal-derived drugs: a pharmacist.
The responsible person must complete the required training, be present throughout operating hours, and may not serve several sites at the same time. Under the 2021 notification on additional duties, licensees must sell only through approved channels and report adverse reactions.
Selling: general sale, healthcare facilities only, or a sales licence
A licence to sell traditional drugs issued under the old drug law stays valid until it expires under Section 124. After that, selling a herbal product depends on the sales channel each product has. There are three main routes.
1. General-sale herbal products. The Ministry of Public Health notification on general-sale herbal products B.E. 2569 (2026) cancels four earlier notifications on the subject, including those of 2023 and 2024. Sellers of these products need no sales licence. They include herbal drugs in list 1, which holds 81 Thai traditional formulas and 7 herbal-derived drugs, and drugs for conditions people can manage themselves in the property groups of list 2. Products already registered, detailed-notified or notified as general-sale products are deemed general-sale products under the new notification.
2. Products sold only to healthcare facilities. The 2023 Ministry of Public Health notification names herbal drugs that may be sold only to healthcare facilities, such as drugs for listed disease groups under Thai or Chinese traditional medicine and drugs containing realgar, orpiment or cinnabar. Manufacturers and importers may sell them only to healthcare facilities, or to licensed sellers who supply facilities. The second edition of 2026 cancels the original list 1 and replaces it with 18 Thai traditional formulas, and products approved earlier are deemed facility-only products under the new list.
3. Products whose sellers need a sales licence. Clause 5 of the 2020 licensing notification requires sellers of herbal products to hold a sales licence, except for general-sale products. A sales site needs at least one responsible person who is a Thai traditional medicine practitioner, a Chinese medicine practitioner or a pharmacist, and herbal-derived drugs need a pharmacist unless listed for sale in Thai traditional medicine shops.
Two exemptions matter. Under the second paragraph of Section 20, a manufacturing or import licensee is deemed licensed to sell the products it makes or imports. Under Section 18 (8), selling herbal products in a drug store licensed under the drug law needs no separate herbal sales licence.
Preparation of Thai traditional medicines by practitioners
Section 18 of the Herbal Products Act exempts certain practitioners caring for their own patients from the Section 17 licence:
- Section 18 (2): preparing Thai traditional medicines for their own individual patients by Thai traditional medicine practitioners, applied Thai traditional medicine practitioners or certified folk healers, and preparing alternative medicine drugs under the Minister's notification.
- Section 18 (3): repacking herbal products for their own individual patients.
- Section 18 (4): selling herbal products, or those repacked products, to their own individual patients.
Rules still apply under the 2023 notification on preparing, repacking and selling medicines for practitioners' own patients:
- practitioners prepare medicines at a licensed healthcare facility, a herbal product sales site, the patient's residence or another place the Thai Traditional Medicine Council designates, and at the same place the patient receives care
- labels on prepared medicines show at least the place of preparation, the patient's name, the medicine name, directions, indications or properties, and any warnings
- folk healers prepare medicines according to folk medicine knowledge within their certified community, and may repack or sell only the Thai traditional medicines they prepare themselves
- only approved or self-prepared products may be repacked or sold, and adverse reactions must be reported
For Chinese medicine, a 2022 notification counts preparation by licensed Chinese medicine practitioners as alternative medicine preparation, and a 2024 notification names them healthcare professionals under the Act.
The exemption covers a practitioner's own patients only. A clinic or healer that wants to sell its formula as a retail product must follow the normal route of a manufacturing licence and product evidence.
What holders of an old traditional drug registration should check now
If you hold a traditional drug registration issued under the Drug Act B.E. 2510, or have just acquired an older Thai herbal medicine brand, check the following now.
1. Expiry of registrations and licences. Old drug registrations expire according to the registration period set in clause 16 of the 2020 Ministerial Regulation. Under the Thai FDA renewal notification, renewals are filed electronically before expiry. If a certificate lapses beyond the grace period the notification allows, it cannot be renewed; you must apply again for registration, detailed notification or notification, and may not manufacture or import until approved.
2. Name and label. The Herbal Products Committee notification on names, labels and package inserts of herbal products B.E. 2568 (2025) replaces the 2021 version. Labels of herbal drugs need 17 items, including the name, active ingredients and amounts, product type, the sales channel in a green box for general sale or a red box for facility-only products, the words "do not ingest" in red for non-oral products, and the registration number. The product name must be in Thai. Existing labels may be used for a transitional period set by the notification. The details are in herbal product names and labels under the 2025 notification.
3. Sales channel. Compare your formula with the 2026 general-sale and facility-only lists so the label matches.
4. Changes. Clause 10 of the 2020 Ministerial Regulation requires an application with documents to change approved details, except minor changes that do not affect quality, efficacy or safety, which can be made first and reported as the notifications allow.
- ✓Expiry of every registration and licence
- ✓Product name in Thai under the 2025 notification
- ✓All 17 label items and the sales-channel box
- ✓Whether the formula is on the general-sale or facility-only list
- ✓Whether a change needs prior approval or later notice
- ✓A responsible person qualified for the product type
Checklist for Thai traditional and herbal medicines under current law
Use this list before manufacturing, importing or selling Thai traditional and herbal medicines under current law.
- Confirm whether the product is a Thai traditional medicine, an alternative medicine drug, a herbal-derived drug, a herbal health product, or not a herbal product at all.
- List every old traditional drug registration and licence with its expiry, and plan renewal or a new filing under the herbal products law.
- Compare the formula with the 2026 fourth-edition lists to see whether it fits notification, detailed notification or registration.
- Fix the sales channel using the 2026 general-sale and facility-only notifications.
- Make sure manufacturing, import and sales sites hold licences under the new law, with a responsible person qualified for the product type.
- Bring the name and label in line with the 2025 notification, including the sales-channel box and shelf life.
Search the full notifications in the Thai FDA law library, ask case-specific questions with the Thai FDA question assistant, and if you want our team to prepare a renewal, a new filing or an amendment, see registration and notification and document preparation. If you plan to ship abroad, read exporting herbal products from Thailand.
Frequently asked questions
What is a traditional drug (ya phaen boran) in Thai law?
Under Section 4 of the Drug Act B.E. 2510, a traditional drug is a drug intended for traditional medical or veterinary practice that appears in a traditional drug pharmacopoeia announced by the Minister, is declared a traditional drug by the Minister, or is registered as a traditional drug formula. Traditional drugs for human use now fall under the Herbal Products Act B.E. 2562.
Is an old traditional drug registration still valid?
Yes, until it expires, under Section 125 of the Herbal Products Act. Products made or imported before it expires may be sold until the product expires or the authority orders otherwise. Expiry points differ according to when the registration was granted.
Does an old licence to manufacture or sell traditional drugs need replacing?
Licences issued under the Drug Act remain valid until they expire under Section 124. After that, you need a licence to manufacture, import or sell herbal products under the new Act.
What is the difference between a traditional drug and a Thai traditional medicine?
Traditional drug is a term from the old drug law. Thai traditional medicine is a term from the Herbal Products Act, meaning a herbal drug intended for use according to Thai traditional medical knowledge. Most former traditional drugs are now Thai traditional medicines.
Do I need a licence to sell Thai traditional medicines?
Not if the product is a general-sale herbal product under the 2026 notification. For other products the seller needs a sales licence, except manufacturers or importers selling their own products and drug stores licensed under the drug law.
Can a Thai traditional medicine practitioner prepare medicine for patients without a licence?
Yes, for their own individual patients under Section 18 (2), but they must follow the 2023 notification on where medicines are prepared, how prepared medicines are labelled and how adverse reactions are reported.
Sources
- Drug Act B.E. 2510 (1967) — Section 4 definition of traditional drug, Section 49 traditional drug licences · Open source · Search our archive
- Herbal Products Act B.E. 2562 (2019) — Sections 3, 4, 17, 18, 20, 34, 45 and transitional Sections 124–127 · Open source · Search our archive
- Ministerial Regulation on licences to manufacture, import or sell herbal products B.E. 2563 (2020) · Open source · Search our archive
- Ministerial Regulation on registration, detailed notification and notification of herbal products B.E. 2563 (2020) · Open source · Search our archive
- MOPH notification on herbal products requiring a licence to manufacture, import or sell B.E. 2563 (2020) · Open source · Search our archive
- MOPH notification on the qualifications, number and duties of responsible persons at herbal product sites B.E. 2565 (2022) · Open source · Search our archive
- MOPH notification on additional duties of licensees and responsible persons B.E. 2564 (2021) · Open source · Search our archive
- MOPH notification on herbal products requiring registration, detailed notification or notification (No. 4) B.E. 2569 (2026) · Open source · Search our archive
- MOPH notification on herbal products requiring registration, detailed notification or notification (No. 3) B.E. 2566 (2023), lists replaced by No. 4 of 2026 · Open source · Search our archive
- MOPH notification on general-sale herbal products B.E. 2569 (2026) · Open source · Search our archive
- MOPH notification on herbal products sold only to healthcare facilities B.E. 2566 (2023) · Open source · Search our archive
- MOPH notification on herbal products sold only to healthcare facilities (No. 2) B.E. 2569 (2026) · Open source · Search our archive
- MOPH notification on preparing Thai traditional and alternative medicine drugs and repacking or selling herbal products for practitioners' own patients B.E. 2566 (2023) · Open source · Search our archive
- MOPH notification on preparing alternative medicine drugs for practitioners' own patients B.E. 2565 (2022) · Open source · Search our archive
- MOPH notification designating healthcare professionals under the Herbal Products Act B.E. 2567 (2024) · Open source · Search our archive
- MOPH notification on texts related to herbal products B.E. 2565 (2022) · Open source · Search our archive
- MOPH notification on texts related to herbal products (No. 2) B.E. 2568 (2025) · Open source · Search our archive
- Herbal Products Committee notification on names, labels and package inserts of herbal products B.E. 2568 (2025) · Open source · Search our archive
- Questions and answers on the 2025 herbal product names and labels notification (Herbal Products Division) · Open source · Search our archive
- Thai FDA notification on renewing herbal product registration certificates, detailed notifications and notifications · Open source · Search our archive
This article is for general information. It is not a Thai FDA ruling or legal advice, and rules change — check the latest notification or ask an expert before filing or producing. Spotted an error? Tell us and we will correct it
Related articles


